Navigation Links
Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
Date:6/9/2009

Leiden, The Netherlands, June 09, 2009 / b3c newswire / - Dutch biotechnology company Amarna Therapeutics B.V. and the Netherlands Organisation for Applied Scientific Research TNO today announced that they have entered into a collaboration agreement to further develop Amarna’s viral gene delivery platform SVac. Under this agreement, TNO will develop novel methods for the manufacture, formulation and testing of viral gene delivery systems such as the SVac platform of Amarna. The collaboration is partly supported by a co-financing initiative aimed at developing innovative technologies.

“We are very pleased to work with TNO”, said Ben van Leent, CEO of Amarna Therapeutics. “We have developed a revolutionary novel viral gene delivery vector platform technology SVac for producing human therapeutics that have the potential to save lives and improve the quality of life for millions of people worldwide that are suffering from life-threatening or severe chronic diseases. The technology is now available to address the major diseases of our time including genetic disorders, autoimmune diseases, allergies and cancer. Amarna Therapeutics acts at the forefront of the therapeutic vaccination and gene therapy markets. Both markets are rapidly growing to reach an estimated 40 billion Euro’s in 2015. I’m convinced that the therapeutics in our pipeline all have blockbuster potential. The partnership with TNO enables us to initiate the first time in man clinical trials with one of our lead therapeutics in 2010.”

“The partnership between TNO and Amarna allows us to expand our pre-clinical development services into the extremely important therapeutic area of viral vector and gene delivery techno
'/>"/>

b3c newswire

Page: 1 2 3

Related biology news :

1. Continuous glucose monitoring technology -- special issue of Diabetes Technology and Therapeutics
2. NIH announces new program to develop therapeutics for rare and neglected diseases
3. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
4. Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
5. Acorda Therapeutics submits new drug application for Fampridine-SR in multiple sclerosis
6. A novel target for therapeutics against Staph infection
7. Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration
8. Growing fuel and medicine: Advancing biofuels and plant-produced therapeutics
9. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
10. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
11. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... the International Space Station ever starts a "frequent flyers" ... status. Recently the orbiting laboratory has hosted increasing numbers ... returned from the space station in April, and another ... third experiment is planned to launch in December. , ... around the world-- and in space. Model organisms can ...
(Date:9/18/2014)... genetic information is stored in DNA, tiny strands of ... our bodies. To express this genetic data, our DNA ... instructions into proteins that perform tasks in our cells. ... type of RNA molecule. Unlike all other known RNAs, ... Although circRNA molecules are abundant, little has been known ...
(Date:9/18/2014)... to be cheerful, happy-go-lucky characters, so you might expect ... , In fact some dogs are distinctly more ... shows. , "This research is exciting because it ... and non-invasively. It offers researchers and dog owners an ... changes," said Dr Melissa Starling, from the Faculty of ...
Breaking Biology News(10 mins):Buzzing with activity: Fruit flies orbit Earth for science 2Buzzing with activity: Fruit flies orbit Earth for science 3Buzzing with activity: Fruit flies orbit Earth for science 4Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2Dogs can be pessimists too 2Dogs can be pessimists too 3
... or a missed ball can put a crimp in an ... but the processes occurring under the skin remain full of ... blood cells, mobilize to protect injured body tissue from infection. ... othersare attracted to damaged tissue. The response begins when ...
... should abandon the concept of carbon emissions trading in ... to genuine reductions in the amount of carbon dioxide ... mechanism for reducing climate change. Details of the carbon ... Environmental Review . Carbon emissions trading was to ...
... reproductive biologist has achieved a major breakthrough in IVF ... around the world who have suffered previous miscarriages after ... Research Fellow and member of the University,s Robinson Institute, ... product which improves IVF embryo implantation rates for some ...
Cached Biology News:Researchers investigate why a limited number of white blood cells are attracted to injured tissue 2Carbon swap bank to beat climate change 2Carbon swap bank to beat climate change 3IVF breakthrough to hit the world market 2
(Date:9/19/2014)...  An entire month is dedicated to one of ... disease (CMT) – a debilitating neuromuscular disease affecting the ... weakness, and foot and hand deformities. CMT affects 1 ... is a progressive disease, and over time patients lose ... such as leg braces, wheelchairs and scooters to get ...
(Date:9/19/2014)... Charlotte, NC (PRWEB) September 19, 2014 ... Certified Biobased Product Label for its Organic Cotton ... the product’s amount of renewable biobased ingredients meets or ... or intermediate materials composed in whole or in significant ... “This logo/label will allow our Organic cotton to be ...
(Date:9/18/2014)... 2014 Bipartisan passage this week by ... to stimulate development and commercialization of new technologies and ... leaders of SPIE, the international society for optics ... and Innovation (RAMI) Act, now moves to the full ... they are optimistic that it will win passage there ...
(Date:9/18/2014)...  Health Enhancement Products, Inc. (OTCQB: HEPI), a ... and metabolic processes, is pleased to announce the addition of ... Nola E. Masterson , a California ... September 17, 2014. "We,re very pleased and ... states Andrew Dahl , President and CEO. "She joins ...
Breaking Biology Technology:September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Barnhardt Manufacturing Company Earns USDA Certified Biobased Product Certification and Label for Organic Cotton 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2
... BRAY, Ireland, December 20, 2011 Osteologix Holdings, ... 0.06 per sharepayable to shareholders of record on December 19, ... payment date is being delayed to allow time for certain ... the Company by shareholders prior to dividend payment. ...
... The new measurements, by UCLA physics professor Giovanni Zocchi and ... times higher in resolution than previous mechanical measurements, a nanotechnology ... a solid nor a liquid. "Proteins are the molecular ... said. "We have found that sometimes they behave as a ...
... tasks -- may have applications in areas outside of ... and his collaborators. Working at the interface of ... Pitt,s Department of Physics and Astronomy in the Kenneth ... colleagues report their findings in a paper published online ...
Cached Biology Technology:Osteologix Announces Dividend 2Osteologix Announces Dividend 3UCLA physicists report nanotechnology feat with proteins 2Quantum computing has applications in magnetic imaging, say Pitt researchers 2
... and Tissue Staining Kits are intended for ... of histological and cytological specimens. These kits ... manufactured by either R&D Systems or by ... the formation of the Avidin-Biotin Complex (ABC) ...
... jetSI-ENDO is an easy-to-use siRNA transfection ... out endogenous genes in a variety of ... comes with an optimized, straightforward protocol. High ... are obtained following transfection of 20 to ...
... jetSI-ENDO-FluoR is a tetramethylrhodamine-conjugated ... emission at 580 nm), the ... reagents are used to determine ... the intracellular delivery and trafficking ...
... in a Morris Water Maze. Tracks up ... sequence of trials.The Spatial Behavior line is a ... camera, frame grabber, and feature extraction software and ... up to 6 moving animals. Software automatically ...
Biology Products: